Grantham, Mayo, Van Otterloo & Co (GMO)’s Calix CALX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-84,200
Closed -$2.51M 849
2020
Q4
$2.51M Sell
84,200
-12,100
-13% -$299K 0.02% 397
2020
Q3
$1.71M Buy
+96,300
New +$1.82M 0.01% 434
2019
Q3
Sell
-168,800
Closed -$1.11M 731
2019
Q2
$1.11M Sell
168,800
-43,800
-21% -$296K 0.01% 514
2019
Q1
$1.64M Buy
+212,600
New +$1.87M 0.01% 419

Other funds holding CALX

Grantham, Mayo, Van Otterloo & Co (GMO)'s CALX Position: Q1 2021 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Calix (CALX) in Q1 2021, closing a stake of 84,200 shares — an estimated $2.51M sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in CALX in Q1 2019 and held it in 4 quarters. The position peaked at $2.51M in Q4 2020. 198 funds tracked by Wall St. Rank hold CALX as of Q1 2021.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Calix position as of Q1 2021 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 84,200 Calix shares in Q1 2021, an estimated $2.51M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Calix in Q1 2019 and held it in 4 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Calix position peaked at $2.51M in Q4 2020.
  • 198 funds tracked by Wall St. Rank held Calix as of Q1 2021.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2021, filed 13 May 2021.